Publication:


abstract

toll-like receptor (TLR) 2-mediated innate immunity is an important defense system against Mycobacterium tuberculosis infection. Studies on TLR2 protein Expression and downstream cytokines in tuberculosis patients are lacking. TLR2 expression in the peripheral blood monocytes of 87 tuberculosis patients and 94 healthy subjects was evaluated using flow cytometry. TLR2 expression and its downstream cytokines, including interleukin (IL)-6, IL-10, tumor necrosis factor (TNF)-alpha, and interferon-gamma, were correlated with the clinical manifestations and outcomes of tuberculosis. The TLR2 expression in peripheral blood monocytes was higher in tuberculosis patients than in healthy subjects. Among the tuberculosis patients, those aged ≥70 years with disseminated tuberculosis or aged <70 years with symptom duration ≥14 days had lower initial TLR2 expression. After two months of treatment, TLR2 expression decreased in most patients, except in those whose sputum samples remained culture-positive for M. tuberculosis. Proportional hazards regression analyses revealed that high initial TLR2 expression and IL-10 plasma level were associated with shorter survival. TLR2 may play an important role in the course of tuberculosis. Its expression on peripheral blood monocytes and the plasma level of the downstream anti-inflammatory cytokine IL-10 may be important outcome predictors and have potential use in the management of tuberculosis patients.

Related Articles
Toll-like receptor 2 and DC-SIGNR1 differentially regulate suppressors of cytokine signaling 1 in dendritic cells during Mycobacterium tuberculosis infection.
J Biol Chem. 2009
Toll-like receptor 2 and DC-SIGNR1 differentially regulate suppressors of cytokine signaling 1 in dendritic cells during Mycobacterium tuberculosis infection.
Srivastava V, Manchanda M, Gupta S, Singla R, Behera D, Das G, Natarajan K. J Biol Chem. 2009 Sep 18; 284(38):25532-41. Epub 2009 Jul 17.
Impaired expression of Toll-like receptor 2 in nontuberculous mycobacterial lung disease.
Eur Respir J. 2007
Impaired expression of Toll-like receptor 2 in nontuberculous mycobacterial lung disease.
Ryu YJ, Kim EJ, Lee SH, Kim SY, Suh GY, Chung MP, Kim H, Kwon OJ, Koh WJ. Eur Respir J. 2007 Oct; 30(4):736-42. Epub 2007 Jun 13.
Enhanced expression of Toll-like receptor 2 in lesional tissues and peripheral blood monocytes of patients with oral lichen planus.
J Dermatol. 2011
Enhanced expression of Toll-like receptor 2 in lesional tissues and peripheral blood monocytes of patients with oral lichen planus.
Ohno S, Tateishi Y, Tatemoto Y, Morishita K, Sasabe E, Yamamoto T. J Dermatol. 2011 Apr; 38(4):335-44.
Toll-like receptor 2 and 4 ligation results in complex altered cytokine profiles early and late after burn injury.
J Trauma. 2008
Toll-like receptor 2 and 4 ligation results in complex altered cytokine profiles early and late after burn injury.
Cairns BA, Barnes CM, Mlot S, Meyer AA, Maile R. J Trauma. 2008 Apr; 64(4):1069-77; discussion 1077-8.
Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages.
Int J Med Sci. 2008
Differential constitutive and cytokine-modulated expression of human Toll-like receptors in primary neutrophils, monocytes, and macrophages.
O'Mahony DS, Pham U, Iyer R, Hawn TR, Liles WC. Int J Med Sci. 2008 Jan 4; 5(1):1-8. Epub 2008 Jan 4.